“…(1) selective lesioning of noradrenergic neurons (with 6-hydroxydopamine or DSP-4) increases seizure susceptibility to a variety of convulsant stimuli (Arnold et al, 1973;Jerlicz et al, 1978;Mason and Corcoran, 1979;Snead, 1987;Trottier et al, 1988;Sullivan and Osorio, 1991;Mishra et al, 1994); (2) direct stimulation of the locus coeruleus (LC, the major concentration of noradrenergic cell bodies in the C NS) and the subsequent release of N E reduce C NS sensitivity to convulsant stimuli (Libet et al, 1977;T urski et al, 1989); (3) genetically epilepsy-prone rats (GEPRs), a widely used animal model of epilepsy, have deficient presynaptic N E content, N E turnover, tyrosine hydroxylase levels, dopamine -hydroxylase (DBH) levels, and N E uptake (Jobe et al, 1984;Dailey and Jobe, 1986;Browning et al, 1989;Lauterborn and Ribak, 1989;Dailey et al, 1991); and (4) adrenergic agonists acting at the ␣-2 adrenoreceptor (␣2-AR) have anticonvulsant action (Papanicolaou et al, 1982;Baran et al, 1985;Loscher and C zuczwar, 1987;Fletcher and Forster, 1988;Jackson et al, 1991).…”